Collaborative and Other Relationships (Details)			3 Months Ended
	Nov. 03, 2023 USD ($) payment	Nov. 05, 2019 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Nov. 30, 2023
Collaborative and Other Relationships [Line Items]
Revenues			$ 92,761,000	$ 68,778,000
Torii Pharmaceutical Co.
Collaborative and Other Relationships [Line Items]
Revenues		$ 22,000,000
Potential milestone payments receivable if regulatory approval before specified date		$ 15,000,000
Maximum customary reduction on royalty rate		50.00%
Torii Pharmaceutical Co. | Minimum
Collaborative and Other Relationships [Line Items]
Royalty rate if maintains sakigake designation		20.00%
Royalty rate					20.00%
Torii Pharmaceutical Co. | Maximum
Collaborative and Other Relationships [Line Items]
Royalty rate if maintains sakigake designation		40.00%
Royalty rate					80.00%
Clearside Biomedical, Inc.
Collaborative and Other Relationships [Line Items]
Upfront payment	$ 5,000,000
Number of milestone payments | payment	3
Number of royalties tiers | payment	3
Clearside Biomedical, Inc. | Annual Net Sales Of $2 Million
Collaborative and Other Relationships [Line Items]
Annual global net sales	$ 2,000,000,000
Clearside Biomedical, Inc. | Annual Net Sales Greater Than $1.5 Million
Collaborative and Other Relationships [Line Items]
Annual global net sales	1,500,000,000
Clearside Biomedical, Inc. | Maximum
Collaborative and Other Relationships [Line Items]
Potential milestone payment	30,000,000
Potential payment if milestone reached	$ 47,500,000